Guido Francini
About
Guido Francini is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Immunology.
According to data from OpenAlex, Guido Francini has authored 113 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 86 papers in Oncology, 43 papers in Pulmonary and Respiratory Medicine and 18 papers in Immunology. Recurrent topics in Guido Francini's work include Colorectal Cancer Treatments and Studies (35 papers), Cancer Immunotherapy and Biomarkers (21 papers) and Bone health and treatments (18 papers). Guido Francini is often cited by papers focused on Colorectal Cancer Treatments and Studies (35 papers), Cancer Immunotherapy and Biomarkers (21 papers) and Bone health and treatments (18 papers). Guido Francini collaborates with scholars based in Italy, United States and France. Guido Francini's co-authors include Roberto Labianca, Daniel G. Haller, Daniel J. Sargent, Richard M. Goldberg, Jean François Seitz, Roberto Petrioli, Lois E. Shepherd, Pierpaolo Correale, Jacqueline Benedetti and Stefania Marsili and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and The Journal of Immunology.
In The Last Decade
Guido Francini
107 papers receiving 5.2k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Guido Francini Italy | 28 | 4.1k | 1.3k | 1.1k | 934 | 671 | 113 | 5.3k | ||
| Gennaro Galizia Italy | 43 | 2.8k 0.7× | 1.9k 1.5× | 731 0.6× | 1.3k 1.4× | 462 0.7× | 140 | 5.2k | ||
| Nirag Jhala United States | 41 | 3.2k 0.8× | 1.5k 1.2× | 694 0.6× | 2.4k 2.6× | 703 1.0× | 165 | 6.0k | ||
| Dimitrios Pectasides Greece | 43 | 2.9k 0.7× | 1.2k 1.0× | 548 0.5× | 1.3k 1.4× | 690 1.0× | 227 | 6.1k | ||
| Jimmy J. Hwang United States | 32 | 2.5k 0.6× | 814 0.6× | 571 0.5× | 780 0.8× | 833 1.2× | 159 | 4.2k | ||
| Jean‐Philippe Spano France | 38 | 3.0k 0.7× | 1.2k 1.0× | 639 0.6× | 448 0.5× | 501 0.7× | 190 | 5.1k | ||
| Ullrich Graeven Germany | 34 | 2.9k 0.7× | 1.1k 0.9× | 747 0.7× | 781 0.8× | 305 0.5× | 135 | 4.4k | ||
| P. Kosmidis Greece | 39 | 3.9k 1.0× | 2.3k 1.9× | 645 0.6× | 1.0k 1.1× | 257 0.4× | 224 | 6.4k | ||
| Valérie Jooste France | 32 | 2.3k 0.6× | 1.0k 0.8× | 845 0.7× | 960 1.0× | 579 0.9× | 116 | 4.6k | ||
| Jae Kyung Roh South Korea | 30 | 4.2k 1.0× | 1.8k 1.4× | 1.3k 1.2× | 1.2k 1.3× | 322 0.5× | 156 | 5.9k | ||
| Christophe Borg France | 39 | 4.3k 1.1× | 1.7k 1.4× | 789 0.7× | 1.1k 1.2× | 1.1k 1.6× | 227 | 6.3k |
Countries citing papers authored by Guido Francini
Since
Specialization
Citations
This map shows the geographic impact of Guido Francini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guido Francini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guido Francini more than expected).
Fields of papers citing papers by Guido Francini
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Guido Francini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guido Francini. The network helps show where Guido Francini may publish in the future.
Co-authorship network of co-authors of Guido Francini
This figure shows the co-authorship network connecting the top 25 collaborators of Guido Francini. A scholar is included among the top collaborators of Guido Francini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guido Francini. Guido Francini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Petrioli, Roberto, Daniele Marrelli, Franco Roviello, et al.. (2019). Pathological response and outcome after neoadjuvant chemotherapy with DOC (docetaxel, oxaliplatin, capecitabine) or EOF (epirubicin, oxaliplatin, 5-fluorouracil) for clinical T3-T4 non-metastatic gastric cancer. Surgical Oncology. 32. 2–7.
2.
Francini, Guido, et al.. (2019). Clinical outcomes of sunitinib (Su) for patients (pts) with desmoid tumors (DT).. Journal of Clinical Oncology. 37(15_suppl). 11052–11052.
3.
Shi, Qian, Greg Yothers, Thierry André, et al.. (2011). Lymph node (LN) ratio (LNR) risk classification (RC) in stage III colon cancer (CC): A pooled analysis of 16,425 patients from the ACCENT database.. Journal of Clinical Oncology. 29(15_suppl). 3556–3556.
4.
Correale, Pierpaolo, Maria Rotundo, Maria Teresa Del Vecchio, et al.. (2010). Regulatory (FoxP3+) T-cell Tumor Infiltration Is a Favorable Prognostic Factor in Advanced Colon Cancer Patients Undergoing Chemo or Chemoimmunotherapy. Journal of Immunotherapy. 33(4). 435–441.
5.
Licchetta, Antonella, Pierpaolo Correale, Cristina Migali, et al.. (2010). Oral Metronomic Chemo-Hormonal-Therapy of Metastatic Breast Cancer with Cyclophosphamide and Megestrol Acetate. Journal of Chemotherapy. 22(3). 201–204.
6.
Correale, Pierpaolo, Maria Teresa Del Vecchio, Tommaso Renieri, et al.. (2008). Anti-angiogenetic effects of immune-reconstituted influenza virosomes assembled with parathyroid hormone-related protein derived peptide vaccine. Cancer Letters. 263(2). 291–301.
7.
Correale, Pierpaolo, Maria Teresa Del Vecchio, Marco La Placa, et al.. (2008). Chemotherapeutic Drugs may be Used to Enhance the Killing Efficacy of Human Tumor Antigen Peptide-specific CTLs. Journal of Immunotherapy. 31(2). 132–147.
8.
Cusi, Maria Grazia, Maria Teresa Del Vecchio, Chiara Terrosi, et al.. (2005). Immune-Reconstituted Influenza Virosome Containing CD40L Gene Enhances the Immunological and Protective Activity of a Carcinoembryonic Antigen Anticancer Vaccine. The Journal of Immunology. 174(11). 7210–7216.
9.
Correale, Pierpaolo, Maria Grazia Cusi, Maria Teresa Del Vecchio, et al.. (2005). Dendritic Cell-Mediated Cross-Presentation of Antigens Derived from Colon Carcinoma Cells Exposed to a Highly Cytotoxic Multidrug Regimen with Gemcitabine, Oxaliplatin, 5-Fluorouracil, and Leucovorin, Elicits a Powerful Human Antigen-Specific CTL Response with Antitumor Activity in Vitro. The Journal of Immunology. 175(2). 820–828.
10.
Sargent, Daniel J., Harry S. Wieand, Daniel G. Haller, et al.. (2005). Disease-Free Survival Versus Overall Survival As a Primary End Point for Adjuvant Colon Cancer Studies: Individual Patient Data From 20,898 Patients on 18 Randomized Trials. Journal of Clinical Oncology. 23(34). 8664–8670.
11.
Petrioli, Roberto, Stefania Rossi, Daniele Pozzessere, et al.. (2004). Analysis of biochemical bone markers as prognostic factors for survival in patients with hormone-resistant prostate cancer and bone metastases. Urology. 63(2). 321–326.
12.
Correale, Pierpaolo, Angelo Aquino, Antonio Giuliani, et al.. (2003). Treatment of colon and breast carcinoma cells with 5‐fluorouracil enhances expression of carcinoembryonic antigen and susceptibility to HLA‐A(*)02.01 restricted, CEA‐peptide‐specific cytotoxic T cells in vitro. International Journal of Cancer. 104(4). 437–445.
13.
Francini, Guido, Antonio Scardino, Kostas Kosmatopoulos, et al.. (2002). High-Affinity HLA-A(*)02.01 Peptides from Parathyroid Hormone-Related Protein Generate In Vitro and In Vivo Antitumor CTL Response Without Autoimmune Side Effects. The Journal of Immunology. 169(9). 4840–4849.
14.
Petrioli, Roberto, Daniele Pozzessere, Marianna Sabatino, et al.. (2002). Weekly low-dose docetaxel in advanced non-small cell lung cancer previously treated with two chemotherapy regimens. Lung Cancer. 39(1). 85–89.
15.
Correale, Pierpaolo, Maria Grazia Cusi, Marianna Sabatino, et al.. (2001). Tumour-associated antigen (TAA)-specific cytotoxic T cell (CTL) response in vitro and in a mouse model, induced by TAA-plasmids delivered by influenza virosomes. European Journal of Cancer. 37(16). 2097–2103.
16.
Francini, Guido, Roberto Petrioli, Stefano Gonnelli, et al.. (2001). Urinary calcium excretion in the monitoring of bone metastases from prostatic carcinoma. Cancer. 92(6). 1468–1474.
17.
Sargent, Daniel J., Richard M. Goldberg, John S. Macdonald, et al.. (2001). A Pooled Analysis of Adjuvant Chemotherapy for Resected Colon Cancer in Elderly Patients. New England Journal of Medicine. 345(15). 1091–1097.
18.
Francini, Guido, Roberto Petrioli, A. Aquino, & S. Gonnelli. (1993). Advanced breast cancer treatment with folinic acid, 5-fluorouracil, and mitomycin C. Cancer Chemotherapy and Pharmacology. 32(5). 359–364.
19.
Francini, Guido, et al.. (1988). Serum Osteocalcin Concentration in Patients with Prostatic Cancer. American Journal of Clinical Oncology. 11. S83–87.
20.
Francini, Guido, et al.. (1982). Radioimmunoassay for the N-terminal, C-terminal and middle region of human parathyroid hormone in bone diseases.. PubMed. 18(4). 486–92.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Gennaro Galizia Breakdown of academic impact, for papers by Nirag Jhala Breakdown of academic impact, for papers by Dimitrios Pectasides Breakdown of academic impact, for papers by Jimmy J. Hwang Breakdown of academic impact, for papers by Jean‐Philippe Spano Breakdown of academic impact, for papers by Ullrich Graeven Breakdown of academic impact, for papers by P. Kosmidis Breakdown of academic impact, for papers by Valérie Jooste Breakdown of academic impact, for papers by Jae Kyung Roh Breakdown of academic impact, for papers by Christophe Borg